TrialKey is an #AI model that uses big data to design #clinicaltrials and studies more likely to succeed. TrialKey is a technology developed by @OpylAI$OPL
By focusing on participants’ needs from the outset, TrialKey empowers researchers to create trials that are not only effective but also ethical and inclusive, ultimately improving patient outcomes and trial success rates.
Book a demo today: appt.link/minhthu
TrialKey doesn’t just look at the requirements of a single study—it considers the aggregate data of similar studies over decades, allowing it to recommend criteria that will maximise success.
Book a demo here: appt.link/minhthu#clinicaltrials#clinicalresearch
Our AI-powered biostatistical tools provide tailored insights, helping you validate your research question, determine sample sizes, and optimise study protocols for clarity, feasibility, and reliability.
#clinicalresearch#protocoldevelopment#researchquestion#trialdesign
Developing a research protocol is critical in defining the objectives, methodology, and safeguards of a clinical trial. TrialKey offers tailored support to streamline this process, providing researchers with precise, data-backed insights.
Book here: appt.link/minhthu
Every clinical trial incurs costs, from recruitment to analysis. Setting the right criteria helps CROs & sponsors optimise resources, reducing expenses from unsuitable participants & dropouts.
Book a demo: appt.link/minhthu#clinicaltrials#trialdesign#biostatistics
TrialKey’s onboarding program ensures that CRO teams are equipped to use our AI-powered biostatistical validation tools to their fullest, optimising trial efficiency, patient recruitment, and trial success.
Book a demo: appt.link/minhthu#clinicaltrials#ai
Exec Chairman of Opyl joined the Geeks Of The Valley podcast, a series that connects with industry leaders to discuss emerging trends in venture capital, private equity, and innovation.
Listen here: here: open.spotify.com/episode/1iS…#biotech#asx